Moderna’s Scientific Director Stated Some Will Get Sick Despite Coronavirus Vaccine

Israeli doctor Tal Zaks discussed the controversy surrounding the price of the product and the late-stage trials that began last month and in which some 30,000 volunteers are expected to be involved.

RIO DE JANEIRO, BRAZIL - Moderna's biotechnology science director said on Thursday he was "very pleased" with the results of his COVID-19 vaccine, which produced a promising immune response even in elderly patients, although he cautioned that "no Subscribe to our Premium Membership Plan. Already Subscribed?